Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 14 at 2:00 PM EDT

Register Free →
logo
Get CLEATUS

National K12 Program for the Career Development of Clinician-Scientists in Diabetes Research (Diabetes-DOCS)

Active
Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The National K12 Program for the Career Development of Clinician-Scientists in Diabetes Research, known as Diabetes-DOCS, is a forecast opportunity from the National Institutes of Health designed to support physicians pursuing careers in diabetes research. The program primarily focuses on Type 1 Diabetes research through the Statutory Special Diabetes Program, with the potential to expand funding for Type 2 Diabetes research starting in the second year. While a single national administrative center will be awarded, scholars will be supported at their respective home institutions to increase the number of independent physician scientists. Under this program, scholars are prohibited from serving as the lead investigator for independent clinical trials. However, they may participate in clinical trials if the projects are led by an experienced mentor or collaborator. This initiative is authorized under the Public Health Service Act and the American Relief Act of 2025, aiming to address the shortage of pediatric endocrinologists and other physician specialists conducting innovative research into the causes and consequences of diabetes.

General Info

NIDDK funds Diabetes-DOCS program to develop pediatric endocrinology physician-scientists nationwide.

Agency

Department Of Health And Human Services → National Institutes Of Health

NAICS

923120 - Administration of Public Health Programs

Place of Performance

Not specified

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health
Contacts1 person available
OfficeUSA
Organization / AgencyDepartment Of Health And Human Services → National Institutes Of Health
Office AddressUSA
Contacts
Lisa M. Spain Ph.D
contact@example.gov
+1 (555) 000-0000

Full Description

Show more

The NIDDK seeks to advance its mission by funding a program to support the career development of physicians committed to a career in diabetes research. The program is intended to remedy the dearth of pediatric endocrinologists and physicians from other specialties conducting innovative research into the causes and consequences of diabetes. Although there will be one national administrative center awardee, scholars are expected to be appointed and supported at their home institutions around the country. The program will have a focus on Type 1 Diabetes (T1D) research, with the major funding from the Statutory Special Diabetes Program https://www.niddk.nih.gov/about-niddk/research-areas/diabetes/type-1-diabetes-special-statutory-funding-program/about-special-diabetes-program. Starting in the second year, the program may add additional funds if available to support the career development of physicians whose research focuses on innovative projects in type 2 diabetes. The program is expected to deliver on goals to increase the number of physician scientists with independent research careers in the mission of NIDDK https://www.niddk.nih.gov/research-funding/research-programs#diabetes.

This Notice of Funding Opportunity (NOFO) does not allow Scholars to serve as the lead investigator of an independent clinical trial. However, Scholars may engage in clinical trials as part of their research and career development if those trials are led by an experienced mentor. For example, Scholars may propose a separate ancillary study to an ongoing clinical trial; or propose a new trial which is led by a collaborator or mentor. 

Grant authorities that allow NIDDK to forecast this opportunity are as follows: Awards are made under the authorization of Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.

This NOFO is supported under the authority of P.L. 118-158, American Relief Act, 2025; Division C, Section 3102. Extension of special diabetes programs.

Similar Contracts

Same NAICS industry code

NAICS: 923120
New
International
Population Health Monitoring and Authorization Program Services
Solicitation # 2026010460
The University of British Columbia, acting under the Province of British Columbia, is seeking proposals for Population Health Monitoring and Authorization Program Services. This pre-solicitation opportunity, identified by solicitation number 2026010460, focuses on implementing health monitoring and authorization frameworks within the province of British Columbia. Interested parties must submit their responses by the deadline of October 15, 2026. Further details regarding the submission process and specific program requirements can be accessed through the official BC Bid portal.
University of British Columbia

POSTED

3 days ago

DEADLINE

in 11 days
View Details
NAICS: 923120
New
Grant
NIH Operates Under a Continuing Resolution
Solicitation # NOT-OD-26-131
The National Institutes of Health is operating under the Continuing Appropriations and Extensions Act, 2027, which extends government operations through December 11, 2026, at the Fiscal Year 2026 enacted level. Under this resolution, the NIH is prohibited from implementing revisions to the Uniform Administrative Requirements for Federal Awards until the expiration date. Additionally, NIH Institutes and Centers maintain the discretion to issue non-competing research grant awards at levels lower than those listed on the most recent Notice of Award, with potential upward adjustments considered only after FY 2027 appropriations are enacted. All legislative mandates and fiscal policies from FY 2026 remain in effect, including the salary limitation set at Executive Level II of the Federal Pay Scale. The Ruth L. Kirschstein National Research Service Award stipend levels and tuition fees also remain consistent with previous notices. Institutions are expected to monitor their expenditures closely during this period to ensure financial stability until new appropriations are finalized.
National Institutes Of Health

POSTED

6 days ago

DEADLINE

N/A
View Details
NAICS: 923120
Grant
Strengthening Collaboration Between Tuberculosis Control Programs and Affiliated Partners in the United States.The Centers for Disease Control and Prevention is offering funding to a single recipient to enhance collaboration and relationships between tuberculosis control programs, TB controllers, and various affiliated partners across the United States. This initiative builds upon previous efforts to strengthen ties with national TB control programs, federal agencies, academic institutions, businesses, and community or faith-based organizations. The primary goal of this effort is to support the CDC Division of Tuberculosis Elimination in its mission to prevent, control, and eventually eliminate tuberculosis to improve overall health and quality of life. This forecast is managed by the Department of Health and Human Services under the National Center for HIV, Viral Hepatitis, Hepatitis B, and STI, with Martha Boisseau serving as the point of contact.
Centers For Disease Control - Nchhstp

POSTED

10 days ago

DEADLINE

N/A
View Details
NAICS: 923120
SLED
RHTP- Innovative Maternal Care
Solicitation # VDH-26-705-0387
The Virginia Department of Health is seeking projects under the Rural Health Transformation Program to expand maternal healthcare access and infrastructure in rural Virginia. This initiative focuses on improving outcomes through evidence-informed practices in prenatal, perinatal, postpartum, and maternal behavioral health services. Key objectives include strengthening care coordination, integrating substance use disorder services, leveraging telehealth and digital health technologies, and expanding community-based supports such as doulas and peer support. The program targets rural communities as defined by the Federal Office of Rural Health Policy, with a total anticipated funding pool of 11.6 million dollars and individual awards ranging from 50,000 to 1,000,000 dollars. The initial period of performance begins upon the execution of the subaward agreement and ends on September 30, 2027, with potential continuation funding available through September 30, 2030. Awards operate on a cost-reimbursement basis, requiring documentation that costs were paid prior to reimbursement. Applicants must be physically located in or provide direct services to rural Virginia and maintain an active SAM.gov registration. Evaluation is based on a 100-point scale considering quality, feasibility, and overall merit, with funding granted in rank order subject to programmatic priorities and organizational capacity. Applications must be submitted via the eVA portal by October 6, 2026, and include a cover page, executive summary, project narrative, and a detailed budget following 2 CFR Part 200 guidelines.
Virginia Department of Health

POSTED

10 days ago

DEADLINE

in 2 days
View Details
NAICS: 923120
SLED
Notice of Opportunity to Participate in the Implementation Council for One Care
Solicitation # BD-27-1039-EHS01-ASHWA-133664
The Massachusetts Executive Office of Health and Human Services, through MassHealth, is soliciting diverse individuals and representatives from community-based organizations to serve on the Implementation Council for the One Care program. One Care is a coordinated health plan designed for eligible adults ages 21 to 64 that integrates Medicare and MassHealth benefits. The Council's primary purpose is to partner with MassHealth to improve program delivery by monitoring healthcare access, reviewing member experiences, and advising on strategies to strengthen services related to mental health, substance use, and long-term supports. Selected members will serve an initial two-year term, with the possibility of an extension. The commitment involves attending virtual meetings via Zoom twice per month during regular business hours, with each session lasting approximately two hours. Compensation includes a 75 dollar stipend for each council meeting attended and 25 dollars per hour for approved engagement meetings or activities, such as in-person town halls. Applicants are ineligible if they have a direct or indirect employment or contractual relationship with My Ombudsman or a One Care Plan. Applications must be submitted by November 2, 2026, at 5:00 PM via the Mass.gov website, the COMMBUYS portal, or email. Candidates will be evaluated by a committee based on the clarity and completeness of their application, their understanding of the council's goals and responsibilities, and their relevant knowledge and experience with the One Care program. Final selections are made by the Assistant Secretary for MassHealth or a designated official.
EHS01 - EHS

POSTED

13 days ago

DEADLINE

in 29 days
View Details
NAICS: 923120
Grant
Advancing Global Health
Solicitation # DFOP0017890
The Department of State Bureau of Global Health Security and Diplomacy is soliciting Statements of Interest under Annual Program Statement DFOP0017890 to advance the America First Global Health Strategy. This initiative seeks to save lives, strengthen health systems, and foster self-reliance through projects that complement bilateral Memoranda of Understanding with partner governments. With a total estimated funding pool of up to 4.5 billion dollars, the program anticipates up to 100 awards ranging from 500,000 dollars to 250 million dollars each, with performance periods extending up to five years. Funding is available through grants, cooperative agreements, or fixed amount awards. The program is implemented through specific Addenda targeting diverse global health priorities. These include large-scale health system transitions and MOU implementations in Nigeria, Uganda, Malawi, Mozambique, Cameroon, and Cote d'Ivoire, as well as thematic initiatives such as the elimination of neglected tropical diseases, accelerating nutrition progress, rapid outbreak response, child protection, and innovations in population-based surveillance. The application process is a two-step sequence beginning with a Statement of Interest, which is evaluated based on the quality of the program idea, organizational capacity, and the ability to achieve objectives. Recipients must adhere to strict federal regulations, including 2 CFR part 200 and various reporting requirements for subawards and executive compensation. While a Unique Entity Identifier and SAM.gov registration are not required for the initial Statement of Interest phase, they are mandatory for any organization advancing to a full proposal. Technical standards for pharmaceuticals require approval from bodies such as the FDA or WHO. Awardees are expected to implement sustainable, locally led transitions and maintain rigorous financial records aligned with Foreign Assistance Data Review elements.
Bureau Of Global Health Security And Diplomacy

POSTED

14 days ago

DEADLINE

in 4 months
View Details
NAICS: 923120
International
RFI-2026-09-17-MAC
Solicitation # 234169
The Northern Health Authority, operating under the Province of British Columbia, has issued a sources-sought solicitation identified as RFI-2026-09-17-MAC with solicitation number 234169. This request for information is intended to identify potential providers capable of performing work within British Columbia. The solicitation was posted on September 17, 2026, and requires responses to be submitted by the deadline of October 6, 2026, at 11:30 PM. Further details and submission processes can be accessed through the BC Bid portal.
Northern Health Authority

POSTED

17 days ago

DEADLINE

in 2 days
View Details
NAICS: 923120
SLED
27-478HFS-MEDPR-B-54110 | Sole Source Change Order Notice NETSPAP for Illinois Medicaid Program
Solicitation # 27-478HFS-MEDPR-B-54110
This sole source change order notice, identified by solicitation number 27-478HFS-MEDPR-B-54110, pertains to the NETSPAP for the Illinois Medicaid Program. Managed by the Medical Programs agency within the state of Illinois, the contract is centered in Springfield, Illinois, which serves as both the office address and the primary place of performance. The notice was posted on September 16, 2026, and is categorized as a solicitation for a state and local government entity. Karen Mankowski serves as the primary point of contact for this procurement action.
Medical Programs

POSTED

18 days ago

DEADLINE

N/A
View Details
NAICS: 923120
Grant
Cancer Prevention and Control Programs for State, Territorial, and Tribal OrganizationsThe Centers for Disease Control and Prevention's Division of Cancer Prevention and Control is seeking eligible state, territorial, and tribal organizations to implement comprehensive cancer surveillance, prevention, and control strategies. The primary objective is to improve health outcomes through a coordinated approach that integrates clinical preventive services and cancer survivorship to reduce the overall cancer burden in targeted communities. Funding is allocated across three national programs. The National Breast and Cervical Cancer Early Detection Program provides screening and diagnostic services for low-income women without adequate insurance, with an optional component for evidence-based interventions. The National Comprehensive Cancer Control Program supports coalition-led efforts to execute jurisdiction-wide cancer plans, while the National Program of Cancer Registries focuses on the implementation of population-based central cancer registry programs.
Centers For Disease Control - Nccdphp

POSTED

21 days ago

DEADLINE

N/A
View Details
NAICS: 923120
Grant
Native Public Health ResilienceThe Native Public Health Resilience initiative is a forecast opportunity issued by the Indian Health Service under the Department of Health and Human Services. This program is specifically designed to provide funding to Tribes and Tribal Organizations to support the delivery of Essential Public Health Services. The opportunity is managed by the Division of Grants Management, with a posted date of September 10, 2026. Interested parties can coordinate through the provided point of contact or access further details via the official grants.gov portal.
Indian Health Service

POSTED

25 days ago

DEADLINE

N/A
View Details
NAICS: 923120
1 | Page
Solicitation # 376
The Council of State and Territorial Epidemiologists (CSTE), in partnership with the Centers for Disease Control and Prevention (CDC), is offering funding to non-federal public health entities, including state, Tribal, local, and territorial agencies, academic institutions, and nonprofit organizations. The program focuses on promoting One Health collaborations and community education regarding influenza and other zoonotic diseases specifically targeting youth in agriculture. The primary objectives are to develop stakeholder relationships, implement a multisectoral One Health approach to disease prevention, evaluate the impact of public health interventions, and motivate positive behavior changes to prevent the spread of zoonotic infections. Selected awardees will receive a firm-fixed subaward of up to 50,000 dollars per site. The project period runs from October 23, 2026, to July 31, 2027, with final deliverables and invoices due by August 31, 2027. Key deliverables include the formation of a project coordination team, the delivery and evaluation of educational content, and the submission of four written progress reports. Applications are evaluated based on the quality of the proposal, the applicant's understanding of the public health issue, the work plan and budget, and the ability to leverage existing resources. All awards are subject to federal cost principles under 2 CFR 200 and require certifications regarding drug-free workplaces, anti-discrimination compliance, and the prohibition of federal funds for lobbying.
Council of State and Territorial Epidemiologists

POSTED

25 days ago

DEADLINE

in 3 days
View Details
NAICS: 923120
SLED
Bid No. 27-040 2027 Shannon Community Safety Initiative Grant Program
Solicitation # BD-27-1167-PUR02-PUR01-133232
The 2027 Senator Charles E. Shannon Jr., Community Safety Initiative (CSI) Grant Program is a competitive grant opportunity administered by the Springfield Police Department through the Office of Administration and Finance. Funded by the Executive Office of Public Safety and Security (EOPSS), the program utilizes the Office of Juvenile Justice and Delinquency Prevention Comprehensive Gang Model to combat gang and youth violence. It supports regional, multi-disciplinary approaches focusing on coordinated prevention, intervention, law enforcement, prosecution, and reintegration. The anticipated funding cycle runs from January 1, 2027, through December 31, 2027, though the exact start date depends on the state contract. The City of Springfield is applying for a maximum award of $1,000,000.00 from EOPSS, with 67 percent of the total award made available to Shannon Partners. Community-based program agencies are eligible to apply for up to $80,000.00. Preference is given to proposals that target geographical areas with high levels of youth violence, gang activity, and substance abuse, demonstrate a commitment to neighborhood-based strategies, and outline comprehensive plans with multidisciplinary partners. Additionally, city or quasi-city based organizations are expected to provide a 25 percent match from public or private sources. Proposals must be submitted to the Office of Procurement by 2:00 PM on October 5, 2026.
PUR02 - Procurement

POSTED

26 days ago

DEADLINE

in 1 day
View Details

More opportunities from Department Of Health And Human Services → National Institutes Of Health

Same awarding agency

NAICS: 541715
New
Grant
HIV Prevention and Alcohol (R61/R33 Clinical Trials Optional)The National Institutes of Health, under the Department of Health and Human Services, is offering a Phased Innovation Award to advance innovative HIV prevention interventions. This funding opportunity utilizes a two-stage R61/R33 structure to move research from initial development and feasibility testing to larger-scale efficacy and implementation studies. The initial R61 phase focuses on the development, refinement, and pilot testing of novel strategies to address critical scientific and operational questions, ensuring readiness for expanded evaluation across diverse populations. Upon the successful completion of R61 milestones, the R33 phase provides support for expanded testing of interventions and implementation strategies. These studies may evaluate the scalability, sustainability, and clinical management of HIV prevention interventions, specifically including integrated approaches that address alcohol use and related comorbidities. Interested parties can contact the HIV/AIDS and Alcohol Research Program for further information.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

4 days ago

DEADLINE

N/A
View Details
NAICS: 541715
New
Grant
Early to Definitive Clinical Trials (R61/R33 Clinical Trial Required)The National Institutes of Health is forecasting a Notice of Funding Opportunity to solicit applications for early to definitive clinical trials. This initiative seeks proposals testing a wide range of interventions, including drugs, devices, biologics, procedures, and behavioral or social interventions, provided they align with the research missions of the participating NIH Institutes, Centers, and Offices. The funding will utilize a bi-phasic, milestone-driven R61/R33 activity code with a maximum project period of seven years. The R61 phase focuses on planning activities, while the R33 phase supports the actual clinical trial. Although applications are not currently being accepted, this notice serves as an advance alert for investigators with expertise in trial design, implementation, and stakeholder engagement to begin developing collaborations and projects.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

6 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Continuation of the Exceptional Longevity Data Management and Coordinating Center (EL DMCC) (U24 Clinical Trial Not Allowed)The National Institute on Aging intends to issue a single U24 cooperative agreement award to support the continued operation and expansion of the Exceptional Longevity Data Management and Coordinating Center. Serving as the central hub for human longevity translational research, the center integrates deeply phenotyped cohorts and multi-omics datasets to enable cross-cohort analyses and collaborative research. Key responsibilities include data harmonization, the implementation of common data standards, and the management of the ELITE Portal, which provides the research community with secure access to analytical tools and cloud-based computational workspaces. The upcoming funding opportunity will require the Coordinating Center to expand its capabilities in artificial intelligence, machine learning, and the integration of diverse datasets across different species. Future objectives include the development of curated target knowledgebases for therapeutic targets, the enhancement of portal interoperability according to FAIR data principles, and the strengthening of community engagement through specialized training and workshops. This notice serves as a forecast to allow potential applicants to establish collaborations before the official solicitation is released.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

11 days ago

DEADLINE

N/A
View Details
NAICS: 541714
Grant
Immune Drivers of Autoimmune DiseaseThe National Institute of Allergy and Infectious Diseases seeks to support the Immune Drivers of Autoimmune Disease network to investigate the triggers and early mechanisms of autoimmunity in humans. The primary goal is to develop tools for risk prediction and staging, identify pre-clinical immune mechanisms, and utilize artificial intelligence and big data to prevent autoimmune diseases. This initiative emphasizes the creation of preclinical cohorts and the use of remote recruitment and sampling to advance medical research. The network will be managed by a Coordinating Center responsible for data harmonization, sample sharing, and the administration of an Infrastructure Opportunity Fund for collaborative research projects. This forecast, issued by the National Institutes of Health under the Department of Health and Human Services, establishes a framework for shared infrastructure and steering committee oversight to identify common pathways and prevention opportunities.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

11 days ago

DEADLINE

N/A
View Details
NAICS: 513130
Grant
NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed)The National Institutes of Health, through the Department of Health and Human Services, is soliciting applications for the NLM Grants for Scholarly Works in Biomedicine and Health program. This initiative provides funding for the creation of book-length manuscripts and other integrative scholarly works, such as critical reviews and analytical syntheses, designed to benefit U.S. health professionals, scientists, and public health practitioners. The primary goal is to organize and disseminate biomedical and health-related knowledge to improve research, education, and clinical practice. This opportunity is listed as a forecast with a posted date of September 24, 2026. It specifically prohibits the use of clinical trials. Interested parties can contact the NLM Extramural Programs office for further information regarding the application process and program requirements.
Book Publishers

POSTED

11 days ago

DEADLINE

N/A
View Details
NAICS: 541714
Grant
Partnerships for Advancing Development of Diagnostics for Infectious DiseasesThe National Institute of Allergy and Infectious Diseases, under the National Institutes of Health, is seeking to establish partnerships between academic or small business investigators and industrial partners to advance the translational development of diagnostic tests for infectious diseases. This initiative focuses on moving diagnostics that have already demonstrated proof-of-concept through the commercialization process by aligning researchers with experienced industry partners to de-risk development and ensure products are fit for purpose. The program will be supported by a science advisory board and NIAID oversight, incorporating annual meetings and workshops to facilitate collaboration and knowledge exchange. This effort is authorized under the Public Health Service Act and federal regulations to ensure that promising diagnostic technologies are successfully translated into tools for treating and preventing infectious diseases.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

11 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
LeverAging StraTegies to Maximize ImpLementation and Effectiveness for HIV (LAST MILE)The National Institute of Allergy and Infectious Diseases, under the Department of Health and Human Services, is forecasting the LeverAging StraTegies to Maximize ImpLementation and Effectiveness for HIV (LAST MILE) program. This initiative aims to bridge the gap between traditional clinical trial findings and real-world application by supporting collaborations on effectiveness trials, pragmatic trials, and hybrid effectiveness-implementation studies. The program focuses on the prevention and treatment of HIV, including associated coinfections and comorbidities, across all age groups and various points of care. The goal of the program is to advance cross-cutting research in epidemiology, implementation science, and clinical, behavioral, and social sciences. This effort aligns with the broader NIH mission to implement research advances in HIV/AIDS. The opportunity is authorized under the Public Health Service Act and relevant federal regulations, with administrative oversight provided by the Division of AIDS Epidemiology Branch.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

11 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Collaborative Centers in Children’s Environmental Health Research and Translation (P2C Clinical Trial Optional)The National Institutes of Health, under the Department of Health and Human Services, is seeking applications to establish a national network of Children's Environmental Health Research Translation Centers. These centers are designed to protect and improve children's health by developing scientific questions and public health interventions focused on translational research. A primary objective is to move evidence-informed biomedical findings into practical application for the wider community while mentoring a new generation of investigators in the field. Beyond research and translation, the program will function as a national resource to coordinate responses to emerging environmental exposures that impact children. The initiative emphasizes the creation of actionable strategies to prevent harm and ensure a healthy future for children through collaborative efforts within the environmental health community.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

11 days ago

DEADLINE

N/A
View Details
NAICS: 541714
Grant
The Role of the Innate Immune System in the Pathogenesis of Type 1 DiabetesThe National Institute of Allergy and Infectious Diseases, under the Department of Health and Human Services, is forecasting a grant opportunity to investigate the role of the innate immune system in the initiation of Type 1 Diabetes. Funded by the Special Statutory Funding Program for Type 1 Diabetes Research, this initiative seeks to identify genetic and environmental causes of the disease by examining how innate immune components interact with beta cells and pancreatic tissues. The program emphasizes the use of new approach methodologies to determine the timing and impact of environmental triggers that activate these immune pathways. The primary objective is to improve the early identification of high-risk individuals and develop future prevention and therapeutic strategies. This effort is conducted under the authority of the Public Health Service Act and relevant federal regulations. Interested parties can contact the RISP-T1D point of contact for further information regarding this forecast.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

11 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)The National Institute of Neurological Disorders and Stroke (NINDS) is seeking to support scientific research using data from intermediate-size patient population expanded access protocols for Amyotrophic Lateral Sclerosis (ALS). To be eligible, protocols must provide access to an investigational drug or biological product for individuals with ALS and generate data that supports research into the prevention, diagnosis, mitigation, treatment, or cure of the disease. Research goals may include analyzing the effects of products on biomarkers, target engagement, safety and outcome information such as survival and hospitalization, or general patient experience data. This opportunity is currently listed as a forecast by the National Institutes of Health under the Department of Health and Human Services, and applications are not being solicited at this time. The notice serves as a preliminary announcement to allow potential applicants sufficient time to develop responsive projects. Interested parties can contact the ALS Program for further information.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

12 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Research to Improve Rigor, Replicability, and Reproducibility in Biomedical and Behavioral SciencesThe National Institute of Neurological Disorders and Stroke, in collaboration with other NIH entities, is forecasting support for research projects aimed at enhancing biomedical and behavioral rigor, replicability, and reproducibility. Key areas of interest include assessing the scientific impact of these improvements, creating frameworks for selecting high-value replication studies, and measuring the robustness and generalizability of research findings to drive scientific innovation. This notice serves as a forecast to allow potential applicants to establish collaborations and develop responsive projects, as formal applications are not currently being solicited. Interested parties can contact the NINDS Office of Research Quality for further information.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

13 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs)The National Institutes of Health, through the National Institute of Mental Health, is issuing a forecast for a Notice of Funding Opportunity titled Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs). This initiative aims to establish a research network to evaluate the clinical effectiveness, safety, and durability of rapid-acting treatments such as ketamine, esketamine, and psilocybin for individuals with serious mental illnesses. The primary objective is to generate actionable real-world evidence to determine how these interventions can be safely and sustainably integrated into routine clinical practice across diverse patient populations and healthcare settings. By addressing current gaps in knowledge regarding implementation and long-term benefits, the project seeks to inform future healthcare delivery strategies for emerging psychotropic treatments.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

19 days ago

DEADLINE

N/A
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS